Neurobiology of disease · 2025
Data-driven, cross-sectional image-based subtyping and staging of brain volumetric changes in Parkinson's disease.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Park Gilsoon, Ha Jongmok, Lee Jun Seok, Ahn Jong Hyeon, Cho Jin Whan, Seo Sang Won, Youn Jinyoung, Kim Hosung
Аннотация
BACKGROUND: Several subtyping methods have been proposed to characterize Parkinson's disease (PD) progression, yet the trajectory of subcortical and cortical neurodegeneration and its clinical implications remain unclear.
OBJECTIVES: We aimed to conduct a strictly image-based, data-driven classification of PD progression through Subtype and Stage Inference (SuStaIn) algorithm.
METHODS: Brain volumetric data from 565 patients with PD and 150 propensity-matched healthy controls were analyzed. 16 regions of interest, including 9 cortical and 7 deep grey matter structures, were segmented from T1-weighted magnetic resonance images. Clinical data, including REM sleep behavior disorder (RBD), levodopa equivalent daily dose (LEDD), and motor complications were collected. SuStaIn was trained and tested using a 10-folds cross-validation and identified two distinct PD progression subtypes, which were compared for differences in clinical and radiological characteristics.
RESULTS: We found two distinct neurodegenerative trajectories: deep grey matter (DG)-first and cortex (CO)-first. The CO-first subtype had a higher prevalence of RBD (p = 0.009) and levodopa-induced dyskinesia (p = 0.024) than the DG-first subtype. Disease progression was faster in the CO-first subtype (0.203 year/stage, LEDD increase 59.3 mg/year), than in the DG-first subtype (0.081 year/stage, LEDD increase 45.1 mg/year, respectively). Regardless of the subtypes, the sensorimotor and auditory cortices were the earliest affected cortical regions, while the amygdala was the first affected subcortically. A subset of participants (n = 186) showed no significant atrophy progression.
CONCLUSIONS: Our findings support the existence of two distinct subtypes of PD progression based on neuroimaging data. Longitudinal studies are warranted to track their evolution.
OBJECTIVES: We aimed to conduct a strictly image-based, data-driven classification of PD progression through Subtype and Stage Inference (SuStaIn) algorithm.
METHODS: Brain volumetric data from 565 patients with PD and 150 propensity-matched healthy controls were analyzed. 16 regions of interest, including 9 cortical and 7 deep grey matter structures, were segmented from T1-weighted magnetic resonance images. Clinical data, including REM sleep behavior disorder (RBD), levodopa equivalent daily dose (LEDD), and motor complications were collected. SuStaIn was trained and tested using a 10-folds cross-validation and identified two distinct PD progression subtypes, which were compared for differences in clinical and radiological characteristics.
RESULTS: We found two distinct neurodegenerative trajectories: deep grey matter (DG)-first and cortex (CO)-first. The CO-first subtype had a higher prevalence of RBD (p = 0.009) and levodopa-induced dyskinesia (p = 0.024) than the DG-first subtype. Disease progression was faster in the CO-first subtype (0.203 year/stage, LEDD increase 59.3 mg/year), than in the DG-first subtype (0.081 year/stage, LEDD increase 45.1 mg/year, respectively). Regardless of the subtypes, the sensorimotor and auditory cortices were the earliest affected cortical regions, while the amygdala was the first affected subcortically. A subset of participants (n = 186) showed no significant atrophy progression.
CONCLUSIONS: Our findings support the existence of two distinct subtypes of PD progression based on neuroimaging data. Longitudinal studies are warranted to track their evolution.